{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:21:47Z","timestamp":1773231707168,"version":"3.50.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008731","name":"European Leukodystrophies Association","doi-asserted-by":"publisher","award":["ELA 2019-015I2"],"award-info":[{"award-number":["ELA 2019-015I2"]}],"id":[{"id":"10.13039\/501100008731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["GR-2019-12369357"],"award-info":[{"award-number":["GR-2019-12369357"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031271","name":"Fondazione Centro San Raffaele","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["TTAGD0222TT"],"award-info":[{"award-number":["TTAGD0222TT"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ymthe.2025.09.030","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:01:14Z","timestamp":1758614474000},"page":"6226-6247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chimeric enzymes enhance treatment potential for globoid cell leukodystrophy through hematopoietic stem cell gene therapy"],"prefix":"10.1016","volume":"33","author":[{"given":"Federica","family":"Cascino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Ricca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Picciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Valeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Unali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Saporito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Freschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Morena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabata","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kajaste-Rudnitski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-0370","authenticated-orcid":false,"given":"Angela","family":"Gritti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.09.030_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/neup.12967","article-title":"From pathological mechanisms in Krabbe disease to cutting-edge therapy: A comprehensive review","volume":"44","author":"Ketata","year":"2024","journal-title":"Neuropathology"},{"key":"10.1016\/j.ymthe.2025.09.030_bib2","series-title":"GeneReviews\u00ae","first-page":"1993","article-title":"Krabbe disease","author":"Orsini","year":"2000"},{"key":"10.1016\/j.ymthe.2025.09.030_bib3","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1096\/fj.05-3826fje","article-title":"Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophy","volume":"19","author":"Lee","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2025.09.030_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.expneurol.2015.04.020","article-title":"Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy","volume":"271","author":"Matthes","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2025.09.030_bib5","article-title":"Brain-targeted enzyme-loaded nanoparticles: A breach through the blood-brain barrier for enzyme replacement therapy in Krabbe disease","volume":"5","author":"Grosso","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2025.09.030_bib6","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe\u2019s Disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.030_bib7","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.bbmt.2018.06.020","article-title":"Long-Term Functional Outcomes after Hematopoietic Stem Cell Transplant for Early Infantile Krabbe Disease","volume":"24","author":"Allewelt","year":"2018","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.ymthe.2025.09.030_bib8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/GIM.0b013e3181a16e04","article-title":"The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: Report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York","volume":"11","author":"Duffner","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2025.09.030_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.888231","article-title":"Improved Brain Pathology and Progressive Peripheral Neuropathy in a 15 Year Old Survivor of Infantile Krabbe Disease Treated With Umbilical Cord Transplantation","volume":"15","author":"Kofler","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2025.09.030_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.addr.2017.05.004","article-title":"Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives","volume":"118","author":"Solomon","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2025.09.030_bib11","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1182\/bloodadvances.2020001940","article-title":"Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders","volume":"4","author":"Lugt","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.09.030_bib12","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1002\/sctm.20-0481","article-title":"Optimizing allogeneic grafts in hematopoietic stem cell transplantation","volume":"10","author":"Xu","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ymthe.2025.09.030_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1089\/hum.2017.151","article-title":"AAVrh10 Gene Therapy Ameliorates Central and Peripheral Nervous System Disease in Canine Globoid Cell Leukodystrophy (Krabbe Disease)","volume":"29","author":"Bradbury","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.09.030_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1089\/hum.2021.245","article-title":"Efficacy and Safety of a Krabbe Disease Gene Therapy","volume":"33","author":"Hordeaux","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.09.030_bib15","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/mt.2012.153","article-title":"Extended normal life after AAVrh10-mediated gene therapy in the mouse model of krabbe disease","volume":"20","author":"Rafi","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.030_bib16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ymthe.2020.12.031","article-title":"Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease","volume":"29","author":"Li","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.030_bib17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ymthe.2024.02.002","article-title":"High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury","volume":"32","author":"Hordeaux","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.030_bib18","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.ymthe.2022.06.004","article-title":"Evaluating the state of the science for adeno-associated virus integration: An integrated perspective","volume":"30","author":"Sabatino","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.030_bib19","first-page":"2316","article-title":"Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci in mice","volume":"141","author":"Calabria","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.09.030_bib20","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMoa2307798","article-title":"Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne\u2019s Muscular Dystrophy","volume":"389","author":"Lek","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.030_bib21","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.ymthe.2025.03.056","article-title":"Advances in AAV capsid engineering: Integrating rational design, directed evolution and machine learning","volume":"33","author":"Nisanov","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.030_bib22","doi-asserted-by":"crossref","first-page":"P1921","DOI":"10.1016\/j.tibtech.2025.02.016","article-title":"Process and quality considerations for recombinant adeno-associated virus manufacturing platforms","volume":"43","author":"Park","year":"2025","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ymthe.2025.09.030_bib23","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1172\/JCI28873","article-title":"Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice","volume":"116","author":"Biffi","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.09.030_bib24","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1073\/pnas.1205858109","article-title":"Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation","volume":"109","author":"Capotondo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.09.030_bib25","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa2106596","article-title":"Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome","volume":"385","author":"Gentner","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.030_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymthe.2024.12.028","article-title":"Balancing efficacy and safety in lentiviral vector-mediated hematopoietic stem cell gene therapy","volume":"33","author":"Montini","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.030_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41586-024-08250-x","article-title":"Long-term lineage commitment in haematopoietic stem cell gene therapy","volume":"636","author":"Calabria","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.09.030_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.09.030_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1750-3639.1995.tb00601.x","article-title":"The Twitcher Mouse: A Model for Krabbe Disease and for Experimental Therapies","volume":"5","author":"Suzuki","year":"1995","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymthe.2025.09.030_bib30","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00005072-199906000-00009","article-title":"An apoptotic depletion of oligodendrocytes in the twitcher, a murine model of globoid cell leukodystrophy","volume":"58","author":"Taniike","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2025.09.030_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001522","article-title":"Identification of hematopoietic stem cell-specific miRNAs enables gene therapy of globoid cell leukodystrophy","volume":"2","author":"Gentner","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.09.030_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2015.38","article-title":"Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy","volume":"2","author":"Ungari","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.09.030_bib33","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1523\/JNEUROSCI.1802-11.2011","article-title":"Bone marrow transplantation augments the effect of brain- and spinal cord-directed adeno-associated virus 2\/5 gene therapy by altering inflammation in the murine model of globoid-cell leukodystrophy","volume":"31","author":"Reddy","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.09.030_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0009-8981(98)00095-3","article-title":"Expression and processing of recombinant human galactosylceramidase","volume":"276","author":"Nagano","year":"1998","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymthe.2025.09.030_bib35","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/tra.12404","article-title":"Molecular Mechanisms of Disease Pathogenesis Differ in Krabbe Disease Variants","volume":"17","author":"Spratley","year":"2016","journal-title":"Traffic"},{"key":"10.1016\/j.ymthe.2025.09.030_bib36","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1172\/JCI200419205","article-title":"Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells","volume":"113","author":"Biffi","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.09.030_bib37","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708730","article-title":"Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms","volume":"10","author":"Gleitz","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.09.030_bib38","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/hum.2016.068","article-title":"Preclinical Testing of the Safety and Tolerability of Lentiviral Vector-Mediated Above-Normal Alpha-L-Iduronidase Expression in Murine and Human Hematopoietic Cells Using Toxicology and Biodistribution Good Laboratory Practice Studies","volume":"27","author":"Visigalli","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.09.030_bib39","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2009-12-256461","article-title":"The galactocerebrosidase enzyme contributes to the maintenance of a functional hematopoietic stem cell niche","volume":"116","author":"Visigalli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.09.030_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fmolb.2020.00167","article-title":"In vitro Validation of Chimeric \u03b2-Galactosylceramidase Enzymes With Improved Enzymatic Activity and Increased Secretion","volume":"7","author":"Ricca","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymthe.2025.09.030_bib41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/emmm.201202083","article-title":"A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA","volume":"5","author":"Sorrentino","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.09.030_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101127","article-title":"Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy","volume":"31","author":"Ellison","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.09.030_bib43","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1471-4159.2007.05030.x","article-title":"Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain","volume":"104","author":"Zhang","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymthe.2025.09.030_bib44","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/jnr.23847","article-title":"Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe\u2019s disease: Present convictions and future prospects","volume":"94","author":"Hu","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymthe.2025.09.030_bib45","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/hum.2019.008","article-title":"An Engineered Galactosylceramidase Construct Improves AAV Gene Therapy for Krabbe Disease in Twitcher Mice","volume":"30","author":"Pan","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.09.030_bib46","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jbiotec.2006.11.026","article-title":"The level of synthesis and secretion of Gaussia princeps luciferase in transfected CHO cells is heavily dependent on the choice of signal peptide","volume":"128","author":"Knappskog","year":"2007","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.09.030_bib47","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/bit.24776","article-title":"Optimized signal peptides for the development of high expressing CHO cell lines","volume":"110","author":"Kober","year":"2013","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.ymthe.2025.09.030_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/1753-6561-5-S8-O13","article-title":"Enhanced protein synthesis and secretion using a rational signal-peptide library approach as a tailored tool","volume":"5","author":"Stern","year":"2011","journal-title":"BMC Proc."},{"key":"10.1016\/j.ymthe.2025.09.030_bib49","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jgm.677","article-title":"Alteration in the IL-2 signal peptide affects secretion of proteins in vitro and in vivo","volume":"7","author":"Zhang","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2025.09.030_bib50","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/jnr.23762","article-title":"New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones","volume":"94","author":"Spratley","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymthe.2025.09.030_bib51","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/stem.701","article-title":"Neural stem cell gene therapy ameliorates pathology and function in a mouse model of globoid cell leukodystrophy","volume":"29","author":"Neri","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymthe.2025.09.030_bib52","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1523\/JNEUROSCI.4785-13.2014","article-title":"Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A","volume":"34","author":"B\u00f6ckenhoff","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.09.030_bib53","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1093\/hmg\/dds313","article-title":"The galactocerebrosidase enzyme contributes to maintain a functional neurogenic niche during early post-natal CNS development","volume":"21","author":"Santambrogio","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.09.030_bib54","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1093\/hmg\/ddv086","article-title":"Combined gene\/cell therapies provide long-term and pervasive rescue of multiple pathological symptoms in a murine model of globoid cell leukodystrophy","volume":"24","author":"Ricca","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.09.030_bib55","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.stem.2018.10.008","article-title":"Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells","volume":"23","author":"Petrillo","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2025.09.030_bib56","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1182\/bloodadvances.2020003811","article-title":"Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency","volume":"5","author":"Zoccolillo","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.09.030_bib57","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.stemcr.2021.04.011","article-title":"Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes","volume":"16","author":"Mangiameli","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2025.09.030_bib58","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/hmg\/2.11.1841","article-title":"Cloning and expression cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy","volume":"2","author":"Chen","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.09.030_bib59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/bmme.1997.2643","article-title":"Analysis of the 5\u2019 flanking region of the human galactocerebrosidase (GALC) gene","volume":"62","author":"Luzi","year":"1997","journal-title":"Biochem. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.09.030_bib60","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41576-020-00298-5","article-title":"Gene therapy using haematopoietic stem and progenitor cells","volume":"22","author":"Ferrari","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2025.09.030_bib61","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/s41467-022-28762-2","article-title":"A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders","volume":"13","author":"Tucci","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.030_bib62","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1016\/j.ymthe.2022.05.022","article-title":"High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosing","volume":"30","author":"Plasschaert","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.030_bib63","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41591-022-01691-9","article-title":"Hematopoietic stem cell transplantation chemotherapy causes microglia senescence and peripheral macrophage engraftment in the brain","volume":"28","author":"Sailor","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.09.030_bib64","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1038\/s41467-018-07548-5","article-title":"Engrafted parenchymal brain macrophages differ from microglia in transcriptome, chromatin landscape and response to challenge","volume":"9","author":"Shemer","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.030_bib65","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1126\/science.6382609","article-title":"Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse","volume":"225","author":"Yeager","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.09.030_bib66","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/mt.2015.145","article-title":"Long-term improvements in lifespan and pathology in CNS and PNS after BMT plus one intravenous injection of AAVrh10-GALC in twitcher mice","volume":"23","author":"Rafi","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.030_bib67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.34172\/bi.2020.13","article-title":"Conditions for combining gene therapy with bone marrow transplantation in murine Krabbe disease","volume":"10","author":"Rafi","year":"2020","journal-title":"Bioimpacts"},{"key":"10.1016\/j.ymthe.2025.09.030_bib68","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1038\/s41598-017-09958-9","article-title":"Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I","volume":"7","author":"Azario","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.09.030_bib69","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/347188a0","article-title":"Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells","volume":"347","author":"Jones","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.09.030_bib70","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1073\/pnas.95.2.725","article-title":"The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells","volume":"95","author":"Zijlmans","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.09.030_bib71","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66738","article-title":"Subventricular zone\/white matter microglia reconstitute the empty adult microglial niche in a dynamic wave","volume":"10","author":"Hohsfield","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2025.09.030_bib72","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41593-018-0090-8","article-title":"Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion","volume":"21","author":"Huang","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2025.09.030_bib73","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1038\/s41467-024-49908-4","article-title":"CNS-wide repopulation by hematopoietic-derived microglia-like cells corrects progranulin deficiency in mice","volume":"15","author":"Colella","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.030_bib74","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuron.2020.03.031","article-title":"Macrophages Expressing GALC Improve Peripheral Krabbe Disease by a Mechanism Independent of Cross-Correction","volume":"107","author":"Weinstock","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2025.09.030_bib75","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1038\/s41467-020-19179-w","article-title":"Brainstem development requires galactosylceramidase and is critical for pathogenesis in a model of Krabbe disease","volume":"11","author":"Weinstock","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.030_bib76","article-title":"Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial","volume":"174","author":"Brendel","year":"2020","journal-title":"Biochem. Farmacol."},{"key":"10.1016\/j.ymthe.2025.09.030_bib77","doi-asserted-by":"crossref","first-page":"489","DOI":"10.15252\/emmm.201505850","article-title":"Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe-affected non-human primates by intracerebral lentiviral gene therapy","volume":"8","author":"Meneghini","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.09.030_bib78","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nbt1049","article-title":"Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters","volume":"23","author":"Amendola","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.09.030_bib79","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ymthe.2004.11.017","article-title":"Efficient Tet-dependent expression of human factor IX in vivo by a new self-regulating lentiviral vector","volume":"11","author":"Vigna","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.030_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104667","article-title":"Novel bicistronic lentiviral vectors correct \u03b2-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis","volume":"134","author":"Ornaghi","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2025.09.030_bib81","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/cne.22153","article-title":"Effects of developmental age, brain region, and time in culture on long-term proliferation and multipotency of neural stem cell populations","volume":"517","author":"Gritti","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ymthe.2025.09.030_bib82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-0716-1783-0_2","article-title":"Isolation and Culture of Neural Stem\/Progenitor Cells from the Postnatal Periventricular Region","volume":"2389","author":"Ricca","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.09.030_bib83","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1021\/acs.nanolett.3c00377","article-title":"Interactions of Graphene Oxide and Few-Layer Graphene with the Blood-Brain Barrier","volume":"23","author":"Castagnola","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.ymthe.2025.09.030_bib84","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.15252\/emmm.201707922","article-title":"Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells","volume":"9","author":"Piras","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.09.030_bib85","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/bs.mcb.2022.04.012","article-title":"Generation of neuronal\/glial mixed cultures from human induced pluripotent stem cells (hiPSCs)","volume":"171","author":"Mangiameli","year":"2022","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.ymthe.2025.09.030_bib86","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1373\/clinchem.2008.115873","article-title":"Specific determination of \u03b2-galactocerebrosidase activity via competitive inhibition of \u03b2-galactosidase","volume":"55","author":"Martino","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymthe.2025.09.030_bib87","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.omtm.2022.03.011","article-title":"Therapeutic advantages of combined gene\/cell therapy strategies in a murine model of GM2 gangliosidosis","volume":"25","author":"Sala","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.09.030_bib88","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2017.12.431","article-title":"Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature","volume":"123","author":"Voorink-Moret","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2025.09.030_bib89","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1373\/clinchem.2006.079012","article-title":"HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma","volume":"53","author":"Groener","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymthe.2025.09.030_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4235","article-title":"A HILIC-MS\/MS method for simultaneous quantification of the lysosomal disease markers galactosylsphingosine and glucosylsphingosine in mouse serum","volume":"32","author":"Sidhu","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ymthe.2025.09.030_bib91","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymthe.2023.11.020","article-title":"Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells","volume":"32","author":"Valeri","year":"2024","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625007580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625007580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:38:09Z","timestamp":1773157089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625007580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":91,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1525001625007580"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.09.030","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric enzymes enhance treatment potential for globoid cell leukodystrophy through hematopoietic stem cell gene therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}